SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-059911
Filing Date
2021-12-09
Accepted
2021-12-09 17:10:12
Documents
14
Period of Report
2021-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20211209.htm   iXBRL 8-K 45561
2 EX-5.1 sndx-ex51_22.htm EX-5.1 11446
3 EX-99.1 sndx-ex991_6.htm EX-99.1 12914
  Complete submission text file 0001564590-21-059911.txt   214632

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sndx-20211209.xsd EX-101.SCH 5677
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20211209_lab.xml EX-101.LAB 20826
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20211209_pre.xml EX-101.PRE 12379
7 EXTRACTED XBRL INSTANCE DOCUMENT sndx-8k_20211209_htm.xml XML 3788
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 211482733
SIC: 2834 Pharmaceutical Preparations